Back
Morphic Holding Vs. Keros Therapeutics Industry Stock Comparison
Buy
52
MORF
Morphic Holding
Last Price:
27.97
Seasonality Move:
25.42%
Sell
24
KROS
Keros Therapeutics
Last Price:
57.85
Seasonality Move:
-20.18%
Buy
52
Morphic Holding (MORF)
is a Buy
Is Morphic Holding a Buy, Sell or Hold?
- The current Morphic Holding [MORF] share price is $27.31. The Score for MORF is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- MORF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
24
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $56.31. The Score for KROS is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MORF Stock Price Chart
What is Morphic Holding's stock price today?
-
The Morphic Holding share price today is $27.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MORF is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $56.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
MORF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.42 | Sell |
| Relative Strength Index (14 RSI): | 34.75 | Sell |
| Chaikin Money Flow: | -195986 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.67 - 32.01) | Sell |
| Bollinger Bands (100): | (27.77 - 35.73) | Sell |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.91 | Sell |
| Relative Strength Index (14 RSI): | 41.65 | Sell |
| Chaikin Money Flow: | -131167 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.79 - 64.13) | Sell |
| Bollinger Bands (100): | (44.29 - 66.27) | Buy |
MORF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.03 | Sell |
| 20-day SMA: | 28.94 | Sell |
| 50-day SMA: | 32.79 | Sell |
| 200-day SMA: | 34.86 | Sell |
| 8-day EMA: | 28.01 | Sell |
| 20-day EMA: | 29.2 | Sell |
| 50-day EMA: | 31.07 | Sell |
| 200-day EMA: | 34.04 | Sell |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.59 | Sell |
| 20-day SMA: | 59.18 | Sell |
| 50-day SMA: | 63.38 | Sell |
| 200-day SMA: | 44.51 | Buy |
| 8-day EMA: | 57.16 | Sell |
| 20-day EMA: | 58.99 | Sell |
| 50-day EMA: | 59.7 | Sell |
| 200-day EMA: | 49.99 | Buy |
Morphic Holding Earnings Growth & MORF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.30 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.20 per share, an increase this year of $0.03 per share, and a decrease next year of $0.37 per share.
Morphic Holding Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||